Enliven Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Enliven Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2021 to Q3 2024.
  • Enliven Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $85K, a 79.4% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $85K -$328K -79.4% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $169K -$322K -65.6% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $252K -$316K -55.6% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $335K -$309K -48% Dec 31, 2023 10-K 2024-03-14
Q3 2023 $413K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $491K +$46K +10.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $568K -$1.91M -77.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $644K -$8K -1.23% Dec 31, 2022 8-K 2023-06-23
Q2 2022 $445K -$336K -43% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $2.48M +$1.63M +193% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $652K Dec 31, 2021 10-K 2022-03-15
Q3 2021 $716K Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $781K Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $846K Mar 31, 2021 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.